Sadra Medical Journal

Determination of Differences in Meta-Cognitive Beliefs, Life-Orientation, Positive and Negative Affection between Rheumatoid Arthritis Patients with and without Metabolic Syndrome and Normal individuals

Document Type : Original Article

Authors

Maryam Fatemi 1
Azam Davoodi 2

1 M.A. Clinical Psychology, Department of Psychology, Shiraz Branch, Islamic Azad University, Shiraz, Iran

2 Ph.D. Assistant Professor, Department of Psychology, Shiraz Branch, Islamic Azad University, Shiraz, Iran

https://doi.org/10.30476/smsj.2020.84095.1076
Abstract
Introduction: Rheumatoid Arthritis is an auto-immune, systemic, chronic, and inflammatory disease, which may lead to the Cardio-Vascular Diseases (CVD). Metabolic Syndrome (Met S) is considered as a risk factor for developing CVD while the level of mental health has an essential role in their occurrence and intensification. Therefore, the purpose of this study was to determine the differences in Meta-cognitive beliefs, Life-Orientation, positive and negative Affection between Rheumatoid Arthritis Patients with and without Met S and normal individuals in Shiraz city in 2019.
Methods: It is a comparative study. The participants of this study were 70 patients with Met S and 70 patients without Met S and 70 normal individuals who were selected by purposive sampling method and were matched in terms of features as age, gender, and marital status. The data were collected by using Wells-Meta-cognitive beliefs questionnaire, Life-Orientation-Reviewed Sheerer and Kurver, Positive and Negative Affection questionnaire by Watson, Clark, and Tellegen. Reliability was evaluated using Cronbach's alpha method. Data were analyzed using variance multi-variable Statistical analysis and Tukey’s post-hoc test in SPSS software, version 25.
Results: The results showed a significant difference among the three groups in terms of meta-cognitive beliefs (p=0.001) and optimism-pessimism, and Positive Affection (p < 0.01); However, a significant difference was not found in the Negative Meta-cognitive beliefs component (p=0.52) and Negative Affection (p=0.07).
Conclusion: The Rheumatoid Arthritis as a chronic disease and its co-occurrence with Met S both have a considerable impact on the CVD. Also, Patients’ mental health can contribute to reducing anxiety and stress happening due to an illness. Besides, patients’ mental health interventions is recommended along with medications.

Keywords

Rheumatoid Arthritis
Metabolic Syndrome
Cognition
Affect
Emotions
  1. Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet.  2010; 376(9746):1094–1108
  2. Radner H, Lesperance T, Accortt NA, Solomon DH. Incidence and prevalence of cardiovascular risk factors among patients with rheumatoid arthritis, psoriasis, or psoriatic arthritis. Arthritis Care Res (Hoboken). 2017; 69(10):1510–1518
  3. Kvien TK, Uhlig T, Odegard S, Heiberg MS. Epidemiological aspects of rheumatoid arthritis: the sex ratio. Ann N Y Acad Sci   2006; 1069:212-222
  4. McDougall C, Hurd K, Barnabe C. Systematic review of rheumatic disease epidemiology in the indigenous populations of Canada, the United States, Australia, and New Zealand. Semin Arthritis Rheum. 2017; 46(5): 675-686
  5. Davatchi F, Sandoughi M, Moghimi N, Jamshidi AR, Tehrani Banihashemi A, Zakeri Z, et al. Epidemiology of rheumatic diseases in Iran from analysis of four COPCORD studies. Int J Rheum Dis. 2016; 19(11): 1056 - 1062 (In Persian)
  6. Akbarian M, Salehi I. Rheumatoid arthritis. Tehran: Tehran University of Medical Sciences; 2006. P. 84. (In Persian)
  7. Knittle K, Maes S, De Gucht V. Psychological interventions for rheumatoid arthritis: examining the role of self-regulation with a systematic review and meta-analysis of randomized controlled trials. Arthritis Care Res (Hoboken) .2010; 62: 1460– 1472
  8. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001; 285(19):2486-2497
  9. Targher G, Bertolini L, Tessari R, Zenari L, Arcaro G. The International Diabetes Federation definition of the metabolic syndrome independently predicts   future   cardiovascular   events in Type 2 diabetic patients. The Valpolicella Heart Diabetes Study. Diabetic Med. 2006; 23(11):1270-1271
  10. Fauzi NF, Harith RM. Coping with Stress: Evaluation on Metabolic Syndrome Patients in Hospital University Sains Malasyia. Int Med J 2017; 24(1):27-30
  11. Farmanfarma Kh K, Kaykhaei MA, Adineh HA, Mohammadi M, Dabiri S, et al. Prevalence of metabolic syndrome in IRAN: A Meta-Analysis of 69 studies. Diabetes & Metabolic Syndrome: Clin Res & Rev.2018; 13:792-799
  12. Mobini M, Niksolat F, Mohamadpour A, Sadr S, Dashti Dargahloo S. Comparing the prevalence of metabolic syndrome in systemic lupus erythematosus, rheumatoid arthritis and psoriatic arthritis: A cross sectional study. Rheum Res J .2018; 3(2):69-73
  13. Oliveria BMG, Medeiros MMC, Cerqueire JVM, Quixada RTS. Metabolic Syndrome in patients with rheumatoid arthritis followed at a University Hospital in Northeastern Brazil. Rev Bras Rheum Engl Ed .2016; 56(2):117-125
  14. Meissner Y, Richter A, Manger B, Tony HP, Wilden E, Listing J, et al. Serious adverse events and the risk of stroke in patients with rheumatoid arthritis: results from the German RABBIT cohort. Ann Rheum Dis. 2017; 76(9)
  15. Wells A. Meta-cognition and worry: a cognitive model of generalized anxiety disorder. Behavior. Cognitive. Psychother.1995; 23: 301–320. DOI: 10.1017/S1352465800015897
  16. Wells A , Matthews G. Modelling cognition in emotional disorder: the SREF model, J Behav Res and ther .1996; 34: 881-888
  17. Wells A , King P. Meta cognitive therapy for generalized anxiety disorder: An open trial, J Behav Ther and Exp Psychiatry.2006b; 37: 206–212
  18. Wells   A. The anxious thoughts inventory and related measures of metacognition and worry, in book “worry and its psychological disorders; theory assessments and treatment” edited by: Graham, C. L. Davey and Adrian wells. John Wiley & Sons Ltd. England. 2006a; 121-136
  19. Danoff - Burg S, Revenson TA. Benefit - finding among patients with rheumatoid arthritis: Positive effects on interpersonal relationships. J Behve Med.2005; 28(1): 91-103 DOI:10.1007/s10865-005-2720-3
  20. Mohammadi N, Aghayosefi A, Alipour A, Nikrahan G, Sadeghi M, Roohafza H. The Comparison of Negative and Positive Psychological Factors in Patients with Coronary Heart Disease with and without Metabolic Syndrome. J Res Behav Sci. 2018; 15(4): 480-487
  21. Stellar J E, John-Henderson N, Anderson C L, Gordon AM, McNeil G D, et al. Positive affect and markers of inflammation: Discrete positive emotions predict lower levels of inflammatory cytokines. Emotion.2015; 15: 129-135
  22. Moons WG, Eisenberger NI, Taylor SE. Anger and fear responses to stress have different biological profiles. Brain, Behav, Immun.2010; 24: 215–219
  23. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, 3rd, et al. Rheumatoid arthritis classification criteria: An American College of Rheumatology /European League Against Rheumatism collaborative initiative. Arthritis Rheum.2010; 62(9): 2569-2581 DOI: 10.1002/art.27584.
  24. Wells A, Cert wright -Hatton S. A short from of metacognition questionnaire. Behav Res Ther.2004; 42:385-396
  25. Shirinzade Dasstgiri P, Goodarzi AS, Rahimi Ch & Naziri ah. [Factor structure, validity of questionnaire validity Metacognition 30]. J Psych. 1999; 12 (4): 461-445 (In Persian)
  26. Scheier MF, Carver CS, Bridges MW. Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): A reevaluation of the Life Orientation Test. J Pers Soc Psych .1994; 67(6): 1063-1078
  27. Kajbaf MB, Oreyzi Samani Sm, Khodabakhshi M. Standardization, reliability, and validity of optimism scale in Esfahan and a survey of relationship between optimism, selfmastery, and depression. Psych Stu. 2006; 2(1-2): 51-68 )In Persian(
  28. Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: The PANAS scales. J Pers Soc Psych 1988; 54(6): 1063-1070
  29. Bakhshipour R, Dezhkam M. A confirmatory factor analysis of the positive affect and negative affect scales (PANAS). J Psych. 2006; 9(4): 351-365 (In Persian)
  30. Rogers HL, Brotherton HT, Olivera Plaza SL, Segura Duran MA, Pena Altamar ML. Depressive and anxiety symptoms and social support are independently associated with disease-specific quality of life in Colombian patients with rheumatoid arthritis. Rev Bras Rheum 2015; 55(5) :406-413
  31. Cohen BE, Panguluri P, Na B, Whooley MA. Psychological risk factors and the metabolic syndrome in patients with coronary heart disease: Findings from the Heart and Soul Study. Psychiatry Res 2010; 175(1-2): 133-137
  32. Rosmond R, Bjorntorp P. The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke. J Int Med .2000; 247: 188-197
  33. Kop WJ, Gottdiener JS. The role of immune system parameters in the relationship between depression and coronary artery disease. Psycho Med.2005; 67: 37-41
  34. Kwissa - Gajewska. Z., Gruszczyn ´ska.E Relationship between daily pain and affect in women with rheumatoid arthritis: lower optimism as a vulnerability factor. J Behav Med .2018 ; 41: 12–21
  35. Neili Xu,  Zhao S,  Xue H, Fu W,  Liu L,  Zhang T, et al. Associations of perceived social support and positive psychological resources with fatigue symptom in patients with rheumatoid arthritis. PLOS ONE. 2017; 12(3): e0173293.
  36. Mohammadi   L, Besharat MA, Rezazade MR, Lavasani MG. The mediating role of positive and negative affect in the relationship between meaning in life and mental health. J Psych .2018; 22:157-171.
Sadra Medical Journal
Volume 8, Issue 2
April 2020
Pages 123-138

Home

Guide for Authors

Submit Manuscript

Guide for Reviewers

Contact Us